Groups/pregnant outcomes | DEX | ECS | G-CSF | G-CSF + AXaIUsc | GH | HCG | PBMC | PRP | PRP + G-CSF | PRP + G-CSFsc | Placebo |
---|---|---|---|---|---|---|---|---|---|---|---|
Control | 2.76 (1.16, 5.81) | 1.36 (0.64, 2.64) | 2.58 (1.90, 3.43) | 3.34 (1.38, 8.19) | 2.80 (1.14, 6.60) | 2.27 (1.76, 3.01) | 3.03 (2.42, 4.07) | 3.07 (2.30, 3.88) | 2.90 (1.19, 10.06) | 1.51 (0.41, 4.59) | 1.59 (1.18, 2.06) |
DEX | Â | 0.46 (0.17, 1.47) | 0.88 (0.41, 2.35) | 1.16 (0.39, 4.34) | 0.95 (0.32, 3.44) | 0.83 (0.37, 2.07) | 1.11 (0.52, 2.80) | 1.09 (0.49, 2.67) | 1.09 (0.31, 5.09) | 0.49 (0.13, 2.06) | 0.56 (0.25, 1.43) |
ECS | Â | Â | 1.89 (0.90, 4.28) | 2.46 (0.86, 7.94) | 2.17 (0.66, 6.45) | 1.67 (0.83, 3.81) | 2.22 (1.14, 5.23) | 2.40 (1.07, 4.94) | 2.22 (0.74, 9.51) | 1.08 (0.25, 4.05) | 1.17 (0.56, 2.55) |
G-CSF | Â | Â | Â | 1.31 (0.54, 3.18) | 1.11 (0.46, 2.55) | 0.89 (0.66, 1.29) | 1.19 (0.89, 1.75) | 1.23 (0.79, 1.71) | 1.16 (0.45, 3.97) | 0.60 (0.15, 1.99) | 0.62 (0.46, 0.85) |
G-CSF + AXaIUsc |  |  |  |  | 0.87 (0.25, 2.65) | 0.64 (0.28, 1.72) | 0.89 (0.38, 2.33) | 0.94 (0.35, 2.24) | 0.87 (0.25, 3.84) | 0.45 (0.09, 1.98) | 0.48 (0.19, 1.15) |
GH | Â | Â | Â | Â | Â | 0.79 (0.35, 2.09) | 1.08 (0.47, 2.85) | 1.13 (0.43, 2.68) | 1.05 (0.33, 4.68) | 0.51 (0.10, 2.40) | 0.56 (0.23, 1.38) |
HCG | Â | Â | Â | Â | Â | Â | 1.36 (1.00, 1.89) | 1.35 (0.88, 1.98) | 1.26 (0.51, 4.43) | 0.66 (0.17, 2.04) | 0.69 (0.51, 0.89) |
PBMC | Â | Â | Â | Â | Â | Â | Â | 1.00 (0.67, 1.36) | 0.95 (0.37, 3.27) | 0.50 (0.12, 1.54) | 0.52 (0.37, 0.67) |
PRP | Â | Â | Â | Â | Â | Â | Â | Â | 0.96 (0.36, 3.47) | 0.44 (0.13, 1.54) | 0.49 (0.37, 0.76) |
PRP + G-CSF |  |  |  |  |  |  |  |  |  | 0.50 (0.07, 2.02) | 0.53 (0.15, 1.37) |
PRP + G-CSFsc |  |  |  |  |  |  |  |  |  |  | 1.06 (0.32, 3.93) |